8-K
Current Report
Adaptimmune Therapeutics PLC Filed Acc 0001558370-24-015525
Results of operations · Exit or restructuring costs
- Item 2.02 Results of operations and financial condition
- Item 2.05 Costs associated with exit or disposal activities
From the SEC's structured data for this filing
Loading adap-20241113x8k.htm…